Letter: Norwegian scabies during immunosuppressive therapy.
D004351:Drug Resistance; D001556:Hexachlorocyclohexane / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D009664:Norway; D009824:Ointments; D012532:Scabies / Q000188:drug therapy*; D013455:Sulfur / Q000627:therapeutic use
D009824:Ointments; D001556:Hexachlorocyclohexane; D013455:Sulfur